Format

Send to

Choose Destination
Ugeskr Laeger. 2018 Dec 3;180(49). pii: V08180526.

[Antibodies in patients with chronic inflammatory demyelinating polyneuropathy].

[Article in Danish]

Author information

1
Abdullahi.Ahmed.Mohamed@rsyd.dk.

Abstract

Recent studies have identified specific immunoglobulin (Ig) G4 antibodies against the paranodal proteins neurofascin 155 and contactin 1 in subgroups of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). These patients present with distinct clinical phenotypes and poor response to first-line therapy with intravenous Ig. Detection of these antibodies in patients with CIDP has diagnostic, prognostic, and therapeutic implications. This review summarises the current knowledge on clinical characteristics, pathogenesis and treatment of these patients.

PMID:
30520721

Supplemental Content

Full text links

Icon for Danish Medical Association
Loading ...
Support Center